TSE:AKU - Akumin Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$4.25
  • Forecasted Upside: 8.70 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$3.91
▲ +0.06 (1.56%)
1 month | 3 months | 12 months
Get New Akumin Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AKU and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AKU

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$4.25
▲ +8.70% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Akumin in the last 3 months. The average price target is C$4.25, with a high forecast of C$5.25 and a low forecast of C$3.25. The average price target represents a 8.70% upside from the last price of C$3.91.
Buy
The current consensus among 2 contributing investment analysts is to buy stock in Akumin. This rating has held steady since January 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/22/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/17/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
2/9/2021Clarus SecuritiesReiterated RatingBuy
i
Rating by N. Atkinson at Clarus Securities
10/21/2020National Bank FinancialBoost Price TargetSector PerformC$2.50 ➝ C$3.25
i
8/17/2020Canaccord GenuityBoost Price TargetC$5.00 ➝ C$5.25
i
4/1/2020National Bank FinancialDowngradeOutperform Market Weight ➝ Sector Perform Market Weight
i
Rating by E. Leno at National Bank Financial
3/5/2020National Bank FinancialLower Price TargetC$5.75 ➝ C$5.00
i
9/25/2018National Bank FinancialReiterated RatingOutperform Market Weight
i
Rating by E. Leno at National Bank Financial
(Data available from 4/17/2016 forward)
Akumin logo
Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.
Read More

Today's Range

Now: C$3.91
C$3.82
C$3.92

50 Day Range

MA: C$4.42
C$3.85
C$4.77

52 Week Range

Now: C$3.91
C$2.10
C$4.98

Volume

26,378 shs

Average Volume

47,147 shs

Market Capitalization

C$270.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Akumin?

The following Wall Street analysts have issued stock ratings on Akumin in the last year: Canaccord Genuity, Clarus Securities, and National Bank Financial.
View the latest analyst ratings for AKU.

What is the current price target for Akumin?

2 Wall Street analysts have set twelve-month price targets for Akumin in the last year. Their average twelve-month price target is C$4.25, suggesting a possible upside of 8.7%. Canaccord Genuity has the highest price target set, predicting AKU will reach C$5.25 in the next twelve months. National Bank Financial has the lowest price target set, forecasting a price of C$3.25 for Akumin in the next year.
View the latest price targets for AKU.

What is the current consensus analyst rating for Akumin?

Akumin currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AKU will outperform the market and that investors should add to their positions of Akumin.
View the latest ratings for AKU.

What other companies compete with Akumin?

How do I contact Akumin's investor relations team?

The company's listed phone number is 416-613-1391. The official website for Akumin is www.akumin.com.